BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17225734)

  • 1. [The immune system of the skin and stereotyped reaction patterns in inflammatory skin diseases].
    Jaspars EH
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):948-55. PubMed ID: 17225734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
    Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
    Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
    Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
    J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-homing T cells in cutaneous allergic inflammation.
    Santamaria-Babi LF
    Chem Immunol Allergy; 2006; 91():87-97. PubMed ID: 16354951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigens in skin diseases.
    Saloga J; Knop J
    Eur J Dermatol; 1999; 9(7):586-90; quiz 591. PubMed ID: 10523743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathogenesis of inflammatory dermatoses, especially psoriasis].
    Bos WE; Thio HB; Neumann HA; van der Fits L; Prens EP
    Ned Tijdschr Geneeskd; 2006 Jan; 150(4):179-83. PubMed ID: 16471231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.
    Guttman-Yassky E; Lowes MA; Fuentes-Duculan J; Whynot J; Novitskaya I; Cardinale I; Haider A; Khatcherian A; Carucci JA; Bergman R; Krueger JG
    J Allergy Clin Immunol; 2007 May; 119(5):1210-7. PubMed ID: 17472813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of eczema].
    Krasteva M; Choquet G; Descotes J; Nicolas JF
    Rev Prat; 1998 May; 48(9):945-50. PubMed ID: 11767351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond inflammation: tolerance, immunotherapy and more.
    Goerdt S; Birk R; Dippel E; Orfanos CE
    Eur J Dermatol; 1999 Sep; 9(6):507-13; quiz 514. PubMed ID: 10491511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses.
    de Boer OJ; van der Loos CM; Teeling P; van der Wal AC; Teunissen MB
    J Histochem Cytochem; 2007 Sep; 55(9):891-8. PubMed ID: 17478450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine networks in inflammatory skin diseases.
    Pastore S; Mascia F; Mariotti F; Dattilo C; Girolomoni G
    Eur J Dermatol; 2004; 14(4):203-8. PubMed ID: 15319150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic principles of allergic disease.
    Averbeck M; Gebhardt C; Emmrich F; Treudler R; Simon JC
    J Dtsch Dermatol Ges; 2007 Nov; 5(11):1015-28. PubMed ID: 17976144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alloimmunity and autoimmunity. I. Skin aspects].
    Janin A; Gluckman E; Shulman HM
    Ann Pathol; 1989; 9(3):170-4. PubMed ID: 2667532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and anti-cytokine therapy in the treatment of inflammatory skin disease.
    Groves R
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):162-6. PubMed ID: 15588690
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference.
    Meller S; Lauerma AI; Kopp FM; Winterberg F; Anthoni M; Müller A; Gombert M; Haahtela A; Alenius H; Rieker J; Dieu-Nosjean MC; Kubitza RC; Gleichmann E; Ruzicka T; Zlotnik A; Homey B
    J Allergy Clin Immunol; 2007 Jun; 119(6):1470-80. PubMed ID: 17337293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of allograft inflammatory factor-1 in inflammatory skin disorders.
    Orsmark C; Skoog T; Jeskanen L; Kere J; Saarialho-Kere U
    Acta Derm Venereol; 2007; 87(3):223-7. PubMed ID: 17533487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired blaschkolinear dermatoses.
    Grosshans EM
    Am J Med Genet; 1999 Aug; 85(4):334-7. PubMed ID: 10398254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.